count in Medical Technology
Navigation Links
count in Medical Technology
... a platelet response defined as a platelet count of 50,000 platelets
per microliter and doubling of the baseline platelet count (median:17,000
platelets per microliter). A ...
-- Platelet counts maintained: Platelet count increases of 50,000
platelets per microliter were ...
... or less frequently. The baseline median platelet count in both the placebo and the PROMACTA groups ... Throughout the study, the median platelet count in the placebo group never exceeded ... arm experienced a rise in their median platelet count to 36,000/microliters, with median platelet ...
... that of the patients with a baseline platelet count of less than 30,000/microliters, 73% achieved a platelet count of greater than or equal to 50,000/microliters. ... time after 3 weeks) in order to reach a platelet count of greater than or equal to 50,000/microliters ...
... cell count, including a differential white cell count and platelet count. Absolute neutrophil count should be > or = 1,500 cells/mm(cubed) and ... Patients should have an absolute granulocyte count of at least 1,500 (x 106/l) prior to initiation ...
... Valcyte tablets should not be administered if the absolute neutrophil count is less than 500 cells/micro liter, the platelet count is less than 25,000/micro liter, or the hemoglobin is less than 8 g/dL. ...
... response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: patient's ... is achieved when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five parameters. ...
... ( arm, (p=not significant). -- Of patients with baseline CD4+ cell count less than 200 cells per cubic millimeter, 79 percent of patients in ... the lopinavir/r arm, (p=0.009). -- Of patients with baseline CD4+ cell count greater than 200 cells per cubic millimeter, 79 percent of patients ...
... HIV viral loads (less than 50 copies/mL) at 48 weeks. CD4+ cell count mean increases over 48 weeks were similar for females and males, ... mean increases in CD4+ cell counts than males. In addition, CD4+ cell count mean increases over 48 weeks were similar for whites and non-whites. At 48 ...
... eligibility criterion for enrollment in the study was that patients' CD4+ count (or T-cell count) had to be greater than or equal to 200 cells/mm3. The mean CD4+ count change from baseline increased by at least 60 cells/mm3 for each of the ...
... response (PR) to a CR/CRu. The side effects reported included blood count suppression: 26 percent and 36 percent grade 3/4 neutropenia, 15 percent ... and 31 percent grade 3/4 thrombocytopenia. Six patients had delayed blood count recovery for more than 12 weeks. One patient developed myelodysplasia and ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is less than 1000 per cubic millimeter. Warnings and Precautions also ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is less than 1000/mm3. Warnings and Precautions also include the risk of ...
... placebo arm [p<0.0001]. -- In DUET-1, the mean increase in CD4+ cell count from baseline was 103 cells/mm3 in the INTELENCE arm compared with 74 ... placebo arm [p=0.0025]. -- In DUET-2, the mean increase in CD4+ cell count from baseline was 94 cells/mm3 in the INTELENCE arm compared with 72 ...
... load of greater than or equal to 5,000 copies/mL; there was no CD4+ cell count restriction for study entry. The primary endpoint for the study was the ... lopinavir/r arm. Immunologic Response * The mean increase in CD4+ count from baseline at 48 weeks was 203 cells/mm3 in patients in the ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is < 1000/mm. Warnings and Precautions also include the risk of ...
... 18 years and older. At screening, male patients must have a CD4+ cell count of <400 cells/mm3 and female patients must have a CD4+ cell count of <250 cells/mm3. Patients will have no prior NRTI or NNRTI use of more ...
... response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: ... when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five ....
... are guided by monitoring plasma HIV-1 levels or viral load, CD4-T cell count and the patient's clinical condition. The goal of antiretroviral therapy ... at the DNA level. Using fluorescent colors and a microscope, physicians count the actual number of HER-2 genes present in the cell nucleus. Results from ...
... baseline viral load of 4.85 log10 copies per mL and a median CD4+ cell count of 225 cells per cubic millimeter. Patients were randomized to receive ... viral load ( lopinavir/r arm. -- The median change in CD4+ cell count from baseline was similar between the PREZISTA/r and lopinavir/r arms ...
... educators, young athletes, and youth sports coaches, according to Timothy Donovan, Executive Director, SUNY Youth Sports Institute. "At a recent count there were nearly 500 energy drink brands. Classified as supplements and aggressively marketed, they have a special allure with young people. This ...
... Neutropenia and Agranulocytosis have been reported with antipsychotics, including risperidone. Patients with a pre-existing low white blood cell count (WBC) or a history of leukopenia/neutropenia should have frequent complete blood cell counts during the first few months of therapy. At the first ...
... for about 96 percent of PPI use in the study. Other PPI's, including rabeprazole (Aciphex(R)), were not included in the study due to the patient count for these agents being insufficient to yield reliable results. Clopidogrel is one of the world's most prescribed drugs, and ranked third in US ...
... trials in the U.S.," said Dr. Naka, who serves as co-principal investigator of the DuraHeart Trial. "It is extremely gratifying for us to count Dr. Naka's team among those elite institutions who are investigating Terumo Heart's DuraHeart System and building the empirical body of evidence to ...
... analysis revealed that nine patients, or 31 percent, of the first 29 evaluable subjects achieved a complete response (CR) or CR without full blood count recovery (CRi). The estimated median overall survival (OS) in responders was 10.5 months compared to 5.1 months in non-responders at the time of the ...
... Marqibo treatment. Safety was assessed in the context of efficacy defined as the achievement of a complete response with or without full blood count recovery. Susan O'Brien, M.D., professor in the leukemia department at the University of Texas MD Anderson Cancer Center in Houston, and ...
... participated in a 48-week study at the University of California, Irvine , and were evaluated through physician assessments of inflammatory lesion count (papules and pustules), severity of erythema (redness) and telangiectasia (spider veins) and overall clinical improvement, as well as through patient ...
... of DOXIL - In patients with recurrent ovarian cancer or AIDS-related Kaposi's sarcoma, hematologic toxicity (based on platelet count or absolute neutrophil count) may require dose reduction or delay in administration of DOXIL - In patients with ...
... response rate in the intent-to-treat (ITT) population was 26 percent, with morphologic CR in 24 percent of patients and CR with incomplete blood count recovery (CRi) in 2 percent. The median time to response was three months, and responses were seen in all subgroups of patients, including patients ...
... activity has been maintained. To date, of 18 evaluable patients, one achieved a CRp and five are hypoplastic and are awaiting hematologic count recovery. Three additional patients with bone marrow blast reductions are undergoing second induction cycles of treatment. Patients on Schedule B ...
... each patient, analysis of the TCD blood-flow speeds in the main arteries of the brain, age at the time of TCD screening, and the most recent blood count and hemoglobin saturation were analyzed. The study found that patients who had lower hemoglobin saturations had higher TCD blood-flow ...
... six months from the beginning of therapy) between the two treatment groups. Secondary objectives included overall safety, initial response (platelet count of 50 x 10^9/L after 30 days of treatment), activity of the salvage therapy (dexamethasone/rituximab) in patients not responding to dexamethasone ...
... do not use PROMACTA in an attempt to normalize platelet counts. Follow the dose adjustment guidelines to achieve and maintain a platelet count of > / = 50 x 10(9)/L. Malignancies and Progression of Malignancies: Stimulation of the TPO receptor on the surface of hematopoietic ...
... viral load (HIV RNA) was -2.1, -2.2, -2.3, -2.3 (log10) at weeks 48, 96, 144 and 168, respectively. Mean change from baseline CD4 (cells/microliter) count was +121, +144, +158 and +143 at the same time points. Key Safety Findings Safety analyses were performed on data from all patients who ...
... or less frequently. The baseline median platelet count in both the placebo and the PROMACTA groups ... Throughout the study, the median platelet count in the placebo group never exceeded ... arm experienced a rise in their median platelet count to 36,000/microliters, with median platelet ...
Soyfoods Do Not Impact Sperm Count
... known that of all semen parameters, variation in count (#s of sperm/cc seminal fluid) is highly variable ... when one considers the "range" of "normal" sperm count accepted in our field (20-200,000 million.)" ... fluid volume with equivalent amounts of sperm count as those with lower intakes, neither the volume ...... that of the patients with a baseline platelet count of less than 30,000/microliters, 73% achieved a platelet count of greater than or equal to 50,000/microliters. ... time after 3 weeks) in order to reach a platelet count of greater than or equal to 50,000/microliters ...
... cell count, including a differential white cell count and platelet count. Absolute neutrophil count should be > or = 1,500 cells/mm(cubed) and ... Patients should have an absolute granulocyte count of at least 1,500 (x 106/l) prior to initiation ...
... Valcyte tablets should not be administered if the absolute neutrophil count is less than 500 cells/micro liter, the platelet count is less than 25,000/micro liter, or the hemoglobin is less than 8 g/dL. ...
New Weight Loss Hope for People with Diabetes
... meal program does not require members visit centers to weigh-in or count carbs, calories or points. "People with diabetes have to perform ... approaches, like featuring low glycemic foods and eliminating the need to count calories, carbs or points. These factors make it easy to stay with the ...... response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: patient's ... is achieved when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five parameters. ...
... ( arm, (p=not significant). -- Of patients with baseline CD4+ cell count less than 200 cells per cubic millimeter, 79 percent of patients in ... the lopinavir/r arm, (p=0.009). -- Of patients with baseline CD4+ cell count greater than 200 cells per cubic millimeter, 79 percent of patients ...
... HIV viral loads (less than 50 copies/mL) at 48 weeks. CD4+ cell count mean increases over 48 weeks were similar for females and males, ... mean increases in CD4+ cell counts than males. In addition, CD4+ cell count mean increases over 48 weeks were similar for whites and non-whites. At 48 ...
... eligibility criterion for enrollment in the study was that patients' CD4+ count (or T-cell count) had to be greater than or equal to 200 cells/mm3. The mean CD4+ count change from baseline increased by at least 60 cells/mm3 for each of the ...
... response (PR) to a CR/CRu. The side effects reported included blood count suppression: 26 percent and 36 percent grade 3/4 neutropenia, 15 percent ... and 31 percent grade 3/4 thrombocytopenia. Six patients had delayed blood count recovery for more than 12 weeks. One patient developed myelodysplasia and ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is less than 1000 per cubic millimeter. Warnings and Precautions also ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is less than 1000/mm3. Warnings and Precautions also include the risk of ...
... placebo arm [p<0.0001]. -- In DUET-1, the mean increase in CD4+ cell count from baseline was 103 cells/mm3 in the INTELENCE arm compared with 74 ... placebo arm [p=0.0025]. -- In DUET-2, the mean increase in CD4+ cell count from baseline was 94 cells/mm3 in the INTELENCE arm compared with 72 ...
... load of greater than or equal to 5,000 copies/mL; there was no CD4+ cell count restriction for study entry. The primary endpoint for the study was the ... lopinavir/r arm. Immunologic Response * The mean increase in CD4+ count from baseline at 48 weeks was 203 cells/mm3 in patients in the ...
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is < 1000/mm. Warnings and Precautions also include the risk of ...
... 18 years and older. At screening, male patients must have a CD4+ cell count of <400 cells/mm3 and female patients must have a CD4+ cell count of <250 cells/mm3. Patients will have no prior NRTI or NNRTI use of more ...
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
... of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these ... XR should be discontinued in any patient if the absolute neutrophil count is Warnings and Precautions also include the risk of ...... response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: ... when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five ....
... are guided by monitoring plasma HIV-1 levels or viral load, CD4-T cell count and the patient's clinical condition. The goal of antiretroviral therapy ... at the DNA level. Using fluorescent colors and a microscope, physicians count the actual number of HER-2 genes present in the cell nucleus. Results from ...
... baseline viral load of 4.85 log10 copies per mL and a median CD4+ cell count of 225 cells per cubic millimeter. Patients were randomized to receive ... viral load ( lopinavir/r arm. -- The median change in CD4+ cell count from baseline was similar between the PREZISTA/r and lopinavir/r arms ...
Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
... whom month 6 data were unavailable, was considered a treatment failure (ACR non-responder). Disease Activity Scores are based on a 28 joint count and CRP or an ESR at week 24 (depending on which was the qualifying biomarker). Safety Results The most common clinically ...... educators, young athletes, and youth sports coaches, according to Timothy Donovan, Executive Director, SUNY Youth Sports Institute. "At a recent count there were nearly 500 energy drink brands. Classified as supplements and aggressively marketed, they have a special allure with young people. This ...
CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
... published in Cancer , 60,000 cancer patients in the United States are hospitalized for chemotherapy-related neutropenia - or low white blood cell count - which is a risk for serious infection, and a patient dies every two hours from this complication. Healthcare professionals are highly ...... Neutropenia and Agranulocytosis have been reported with antipsychotics, including risperidone. Patients with a pre-existing low white blood cell count (WBC) or a history of leukopenia/neutropenia should have frequent complete blood cell counts during the first few months of therapy. At the first ...
... for about 96 percent of PPI use in the study. Other PPI's, including rabeprazole (Aciphex(R)), were not included in the study due to the patient count for these agents being insufficient to yield reliable results. Clopidogrel is one of the world's most prescribed drugs, and ranked third in US ...
Schering-Plough Announces Results of the Early ACS Trial
... dependent upon renal dialysis (please see dosing guidelines); caution should be exercised when administering INTEGRILIN to patients with a platelet count <100,000/mm3. Bleeding is the most common complication encountered during INTEGRILIN therapy. The majority of excess major bleeding events were ...... trials in the U.S.," said Dr. Naka, who serves as co-principal investigator of the DuraHeart Trial. "It is extremely gratifying for us to count Dr. Naka's team among those elite institutions who are investigating Terumo Heart's DuraHeart System and building the empirical body of evidence to ...
... analysis revealed that nine patients, or 31 percent, of the first 29 evaluable subjects achieved a complete response (CR) or CR without full blood count recovery (CRi). The estimated median overall survival (OS) in responders was 10.5 months compared to 5.1 months in non-responders at the time of the ...
... Marqibo treatment. Safety was assessed in the context of efficacy defined as the achievement of a complete response with or without full blood count recovery. Susan O'Brien, M.D., professor in the leukemia department at the University of Texas MD Anderson Cancer Center in Houston, and ...
... participated in a 48-week study at the University of California, Irvine , and were evaluated through physician assessments of inflammatory lesion count (papules and pustules), severity of erythema (redness) and telangiectasia (spider veins) and overall clinical improvement, as well as through patient ...
US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream
... and HFL, the world's largest sports regulatory and research lab. Glyc'n Go(TM) is available from leading supplement retailers in 60 count and 16-count individual serving packets. For more detailed information visit www.glycngo.com or call toll free 1-877-GLYCNGO. Hi resolution ...... of DOXIL - In patients with recurrent ovarian cancer or AIDS-related Kaposi's sarcoma, hematologic toxicity (based on platelet count or absolute neutrophil count) may require dose reduction or delay in administration of DOXIL - In patients with ...
... response rate in the intent-to-treat (ITT) population was 26 percent, with morphologic CR in 24 percent of patients and CR with incomplete blood count recovery (CRi) in 2 percent. The median time to response was three months, and responses were seen in all subgroups of patients, including patients ...
... activity has been maintained. To date, of 18 evaluable patients, one achieved a CRp and five are hypoplastic and are awaiting hematologic count recovery. Three additional patients with bone marrow blast reductions are undergoing second induction cycles of treatment. Patients on Schedule B ...
... each patient, analysis of the TCD blood-flow speeds in the main arteries of the brain, age at the time of TCD screening, and the most recent blood count and hemoglobin saturation were analyzed. The study found that patients who had lower hemoglobin saturations had higher TCD blood-flow ...
... six months from the beginning of therapy) between the two treatment groups. Secondary objectives included overall safety, initial response (platelet count of 50 x 10^9/L after 30 days of treatment), activity of the salvage therapy (dexamethasone/rituximab) in patients not responding to dexamethasone ...
... do not use PROMACTA in an attempt to normalize platelet counts. Follow the dose adjustment guidelines to achieve and maintain a platelet count of > / = 50 x 10(9)/L. Malignancies and Progression of Malignancies: Stimulation of the TPO receptor on the surface of hematopoietic ...
... viral load (HIV RNA) was -2.1, -2.2, -2.3, -2.3 (log10) at weeks 48, 96, 144 and 168, respectively. Mean change from baseline CD4 (cells/microliter) count was +121, +144, +158 and +143 at the same time points. Key Safety Findings Safety analyses were performed on data from all patients who ...
Other ContentscanalcanalcanalcanalcanalcanalradialradialradialradialradialradiusradiusradiusradiusradiusradiusradiusmatingmatingmatingmatingrandomrandomrandomrandomrandomrandomrandomrandomrandomcutterrarerarerarerarerarerarerarerarerareframeframeframeframeframeframeOther Tagsdrumdealdealvendorbuysheadssustained
(Date:11/24/2009)... of years it has been prescribed by traditional he...headaches and stomach pain to fever and flu. , No...versity have been able to scientifically prove the...herwise known as Brazilian mint. , Testing this a...y researcher Graciela Rocha was able to show that ...
(Date:11/24/2009)...vel action of a remarkable class of ring-shaped pr...h the Lawrence Berkeley National Laboratory (Berke...ography beamline at the Advanced Light Source (ALS... expression and replication, and are vital to the ...tious agents, such as the human papillomavirus, wh...
(Date:11/24/2009).... (November 24, 2009) New research on bacterial c...stems reveals predictable temporal patterns, sugge...as markers for monitoring climate change in the po... Proceedings of the National Academy of Sciences ...n the six rivers shifted synchronously over time, ...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The 2009 National Autism Conference Sponsored by OxyHealth Returns to Florida 54451 1The 2009 National Autism Conference Sponsored by OxyHealth Returns to Florida 54451 2K States Biosecurity Research Institute Gives Researchers the Tools Needed to Study Diseases That Cost Pig Producers Hundreds of Millions of Dollars E 13552 1K States Biosecurity Research Institute Gives Researchers the Tools Needed to Study Diseases That Cost Pig Producers Hundreds of Millions of Dollars E 13552 2K States Biosecurity Research Institute Gives Researchers the Tools Needed to Study Diseases That Cost Pig Producers Hundreds of Millions of Dollars E 13552 3FAT bastard Wine Drives Breast Cancer Awareness for Seventh Consecutive Year 54442 1FAT bastard Wine Drives Breast Cancer Awareness for Seventh Consecutive Year 54442 2(Date:11/26/2009)...ars, the number of Americans living with diabetes ...n 2009 to 44.1 million in 2034. Over the same peri...g from $113 billion to $336 billion, even with no ... based at the University of Chicago report in the ...of those with diabetes covered by Medicare will ri...
(Date:11/26/2009)...big or too heavy can lead to strains or worse , ...ere may be nothing wrong with stuffing your turkey...e same thing with your suitcase as you pack for ho...ated in 2008 in U.S. hospital emergency rooms, doc...s for luggage-related injuries, such as muscle str...
(Date:11/26/2009)... No more letters from the North Pole, Textsa... messages from Santa , No...perational efficiencies at the North Pole Santa Cl...dren all over the globe informed of his Christmas ...uo;s research department have identified a large a...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a lead...a, today announced the expansion of its services t...t, Dr. Doug Macmillan. , ...is pleased to announce that Dr. Doug Macmillan, an...ed an additional advanced training seminar. RTDen...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free na...az and Yasmin birth control pills who have suffere..., Stroke, Heart Attack or other related cardiac is...all toll free at 1-800-856-6405 or go to the firm&...ill out an online case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3[0] Diabetes cases to double and costs to triple by 2034[2] Pack Right for the Holidays to Avoid the ER[1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental [0] Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills
consultingdrumdealpartnershipsinductdigitizedgradsvendorbuysintegratescommercializeheadsWarssustained
Other Tagsfood 2food 3food 4food 5food 6food 7food 8food 9food 10good 2good 3good 4good 5good 6good 7good 8good 9good 10secret 2secret 3secret 4dietary 2dietary 3dietary 4dietary 5dietary 6dietary 7dietary 8dietary 9dietary 10radiation 2radiation 3radiation 4radiation 5radiation 6radiation 7radiation 8radiation 9radiation 10empty 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |